A 69-year-old woman was admitted to the hospital with double vision, weakness in the lower extremities, sensory loss, pain, and falls. Her symptoms started with sudden onset of horizontal diplopia 6 weeks before, followed by gradually worsening lower-extremity weakness, as well as ataxia and patchy and bilateral radicular burning leg pain more pronounced on the right. Her medical history included narcolepsy, obstructive sleep apnea, hypertension, hyperlipidemia, and bilateral knee replacements for osteoarthritis.
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■ FURTHER EVALUATION AND DIFFERENTIAL DIAGNOSIS 1
Which of the following is the most likely diagnosis at this point?
□ Cerebral infarction □ Guillain-Barré syndrome □ Progressive polyneuropathy □ Transverse myelitis □ Polyradiculopathy
In the absence of defi nitive diagnostic tests, all of the above options were considered in the differential diagnosis for this patient.
Cerebral infarction
Although acute-onset diplopia can be explained by brainstem stroke involving cranial nerve nuclei or their projections, the onset of diplopia with progressive bilateral lower-extremity weakness makes stroke unlikely. Flaccid paralysis, arefl exia of the lower extremities, and sensory involvement can also be caused by acute anterior spinal artery occlusion leading to spinal cord infarction; however, the defi cits are usually maximal at onset.
Guillain-Barré syndrome
The combination of acute-subacute progressive ascending weakness, sensory involvement, and diminished or absent refl exes is typical of Guillain-Barré syndrome. Cranial nerve involvement can overlap with the more typical features of the syndrome. However, most patients reach the nadir of their disease by 4 weeks after initial symptom onset, even without treatment. 1 This patient's condition continued to worsen over 8 weeks. In addition, the asymmetric lower-extremity weakness and sparing of the arms are atypical for Guillain-Barré syndrome.
Given the progression of symptoms, chronic infl ammatory demyelinating polyneuropathy is also a consideration, typically presenting as a relapsing or progressive neuropathy in proximal and distal muscles and worsening over at least an 8-week period. 2 The initial workup for Guillain-Barré syndrome or chronic infl ammatory demyelinating polyneuropathy includes lumbar puncture to assess for albuminocytologic dissociation (elevated protein with normal white blood cell count) in cerebrospinal fl uid (CSF), and electromyography (EMG) to assess for neurophysiologic evidence of peripheral nerve demyelination. In Miller-Fisher syndrome, a rare variant of Guillain-Barré syndrome characterized by ataxia, ophthalmoparesis, and arefl exia, serum ganglioside antibodies to GQ1b are found in over 90% of patients. 3, 4 Although MRI of the spine is not necessary to diagnose Guillain-Barré syndrome, it is often done to exclude other causes of lower-extremity weakness such as spinal cord or cauda equina compression that would require urgent neurosurgical consultation. MRI can support the diagnosis of Guillain-Barré syndrome when it reveals enhancement of the spinal nerve roots or cauda equina.
Other polyneuropathies
Polyneuropathy is caused by a variety of diseases that affect the function of peripheral motor, sensory, or autonomic nerves. The differential diagnosis is broad and involves infl ammatory diseases (including autoimmune and paraneoplastic causes), hereditary disorders, infection, toxicity, and ischemic and nutritional defi ciencies. 5 Polyneuropathy can present in a distal-predominant, generalized, or asymmetric pattern involving individual nerve trunks termed "mononeuropathy multiplex," as in our patient's presentation. The initial workup includes EMG and a battery of serologic tests. In cases of severe and progressive polyneuropathy, nerve biopsy can assess for the presence of vasculitis, amyloidosis, and paraprotein deposition.
Transverse myelitis
Transverse myelitis is an infl ammatory myelopathy that usually presents with acute or subacute weakness of the upper extremities or lower extremities, or both, corresponding to the level of the lesion, hyperrefl exia, bladder and bowel dysfunction, spinal level of sensory loss, and autonomic involvement. 6 The differential diagnosis of acute myelopathy includes; • Infection (eg, herpes simplex virus, West
Nile virus, Lyme disease, Mycoplasma pneumoniae, human immunodefi ciency virus) • Systemic infl ammatory disease (systemic lupus erythematosus, sarcoidosis, Sjögren syndrome, scleroderma, paraneoplastic syndrome)
In the hospital, she underwent lumbar puncture, EMG, and MRI
• Central nervous system demyelinating disease (acute disseminated encephalomyelitis, multiple sclerosis, neuromyelitis optica) • Vascular malformation (dural arteriovenous fi stula) • Compression due to tumor, bleeding, disc herniation, infection, or abscess.
The workup involves laboratory tests to exclude systemic infl ammatory and infectious causes, as well as MRI of the spine with and without contrast to identify a causative lesion. Lumbar puncture and CSF analysis may show pleocytosis, elevated protein concentration, and increased intrathecal immunoglobulin G (IgG) index. 7 Although our patient's presentation with subacute lower-extremity weakness, sensory changes, and bladder dysfunction were consistent with transverse myelitis, her cranial nerve abnormalities would be atypical for it.
Polyradiculopathy
Polyradiculopathy has many possible causes. In the United States, the most common causes are lumbar spondylosis, lumbar canal stenosis, and diabetic polyradiculoneuropathy.
When multiple spinal segments are affected, leptomeningeal disease involving the arachnoid and pia mater should be considered.
Causes include malignant invasion, infl ammatory cell accumulation, and protein deposition, leading to patchy but widespread dysfunction of spinal nerve roots and cranial nerves. Specific causes are myriad and include carcinomatous meningitis, 8 syphilis, tuberculosis, sarcoidosis, and paraproteinemias. CSF and MRI changes are often nonspecifi c, leading to the need for meningeal biopsy for diagnosis.
■ CASE CONTINUED
During her hospitalization, our patient developed acute right upper and lower facial weakness consistent with peripheral facial mononeuropathy. Bilateral lower-extremity weakness progressed to disabling paraparesis.
She underwent lumbar puncture and CSF analysis ( Table 1) . The most notable fi ndings were signifi cant pleocytosis (72% lymphocytic predominance), protein elevation, and elevated IgG index (indicative of elevated intrathecal immunoglobulin synthesis in the central nervous system). Viral, bacterial, and fungal studies were negative. Guillain-Barré syndrome, other polyneuropathies, and spinal cord infarction would not be expected with these CSF features.
Surface EMG demonstrated normal sensory responses, and needle EMG showed chronic and active motor axon loss in the L3 and S1
Her strength, gait, and vision improved with rituximab and methotrexate 
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root distributions, suggesting polyradiculopathy without polyneuropathy. These fi ndings would not be expected in typical acute transverse myelitis but could be seen with spinal cord infarction. MRI of the entire spine with and without contrast showed cauda equina nerve root thickening and enhancement, especially involving the L5 and S1 roots (Figure 1) . The spinal cord appeared normal. These fi ndings further supported polyradiculopathy and a leptomeningeal process.
Further evaluation included chest radiography, erythrocyte sedimentation rate, Creactive protein, hemoglobin A 1c , human immunodefi ciency virus testing, antinuclear antibody, antineutrophil cytoplasmic antibody, extractable nuclear antibody, GQ1b antibody, serum and CSF paraneoplastic panels, levels of vitamin B 1 , B 12 , and B 6 , copper, and ceruloplasmin, and a screen for heavy metals. All results were within normal ranges. 
■ ESTABLISHING THE DIAGNOSIS
2
Which is the best next step in this patient's neurologic evaluation?
□ Test CSF angiotensin-converting enzyme level □ CSF cytology □ Meningeal biopsy □ Peripheral nerve biopsy Given the high suspicion for malignancy, CSF cytology was performed and showed increased numbers of mononuclear chronic infl ammatory cells, including a mixture of lymphocytes and monocytes, favoring a reactive lymphoid pleocytosis. Flow cytometry indicated the presence of a monoclonal, CD5-and CD10-negative, B-cell lymphoproliferative disorder. The immunophenotypic fi ndings were not specifi c for a single diagnosis. The differential diagnosis included marginal zone lymphoma and lymphoplasmacytic lymphoma.
3
Given the presence of serum IgM monoclonal gammopathy in this patient, which is the most likely diagnosis?
Study of bone marrow biopsy demonstrated limited bone marrow involvement (1%) by a lymphoproliferative disorder with plasmacytoid features, and DNA testing detected an MYD88 L265P mutation, reported to be present in 90% Figure 1 . Magnetic resonance imaging of the lumbar spine with contrast showed cauda equina enhancement at level L5 to S1 (arrows) in axial T1 sequence (top) and sagittal T1 sequence (bottom).
of patients with Waldenström macroglobulinemia. 9 This fi nding confi rmed the diagnosis of Waldenström macroglobulinemia with central nervous system involvement. Our patient began therapy with rituximab and methotrexate, which resulted in some improvement in strength, gait, and vision.
■ WALDENSTRÖM MACROGLOBULINEMIA AND BING-NEEL SYNDROME
Waldenström macroglobulinemia is a lymphoplasmacytic lymphoma associated with a monoclonal IgM protein. 10 It is considered a paraproteinemic disorder, similar to multiple myeloma. The presenting symptoms and complications are related to direct tumor infi ltration, hyperviscosity syndrome, and deposition of IgM in various tissues. 11, 12 Waldenström macroglobulinemia is usually indolent, and treatment is reserved for patients with symptoms. 13, 14 It includes rituximab, usually in combination with chemotherapy or other targeted agents. 15, 16 Paraneoplastic antibody-mediated polyneuropathy may occur in these patients. However, the pattern is usually symmetrical clinically, with demyelination on EMG, and is not associated with cranial nerve or meningeal involvement. Management with plasmapheresis, corticosteroids, and intravenous immunoglobulin has not been shown to be effective. 17 Involvement of the central nervous system as a complication of Waldenström macroglobulinemia has been described as Bing-Neel syndrome. It can present as diffuse malignant cell infi ltration of the leptomeningeal space, white matter, or spinal cord, or in a tumoral form presenting as intraparenchymal masses or nodular lesions. The distinction between the tumoral and diffuse forms is based primarily on imaging fi ndings. 18 In a report of 44 patients with Bing-Neel syndrome, 36% presented with the disorder as the initial manifestation of Waldenström macroglobulinemia. 18 The primary presenting symptoms were imbalance and gait diffi culty (48%) and cranial nerve involvement (36%), which presented as predominantly facial or oculomotor nerve palsy. Cauda equina syndrome with motor involvement (seen in our patient) occurred in 14% of patients. Other presenting symptoms included cognitive impairment, sensory defi cits, headache, dysarthria, aphasia, and seizures.
■ LEARNING POINTS
The differential diagnosis for patients presenting with multifocal neurologic symptoms can be broad, and a systematic approach to the diagnosis is necessary. Localizing the lesion is important in determining the diagnosis for patients presenting with neurologic symptoms. The process of localization begins with taking the history, is further refi ned during the examination, and is confi rmed with diagnostic studies. Atypical presentations of relatively common neurologic diseases such as Guillain-Barré syndrome, transverse myelitis, and peripheral polyneuropathy do occur, but uncommon diagnoses need to be considered when support for the initial diagnosis is lacking.
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